Diabetes and chronic kidney disease have an inflammatory response component in common and since the Wnt signaling pathway is involved in this response, studying a role of TCF7L2 gene variants in both diseases can improve the understanding of mechanisms involved in affecting disease risk. Here, TCF7L2 is linked to diabetes mellitus.